A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

H Lokhorst; P Wijermans; E Kneppers; G Huls; S Wittebol; P Sonneveld; E Vellenga; MJ Kersten; S Zweegman; M Schaafsma; RA Raymakers; C Eeltink

doi:https://doi.org/10.1016/s1557-9190(11)70531-5

A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

H Lokhorst, P Wijermans, E Kneppers, G Huls, S Wittebol, P Sonneveld, E Vellenga, MJ Kersten, S Zweegman, M Schaafsma, RA Raymakers, C Eeltink

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S47-S48
Journal	Clinical Lymphoma and Myeloma
Volume	9
DOIs	https://doi.org/10.1016/s1557-9190(11)70531-5
Publication status	Published - 27 Sept 2012

Access to Document

https://doi.org/10.1016/s1557-9190(11)70531-5

http://www.mendeley.com/research/a285-dutch-lenalidomide-named-patient-program-results-feasibility-heavily-pretreated-patients

Cite this

Lokhorst, H., Wijermans, P., Kneppers, E., Huls, G., Wittebol, S., Sonneveld, P., Vellenga, E., Kersten, MJ., Zweegman, S., Schaafsma, M., Raymakers, RA., & Eeltink, C. (2012). A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients. Clinical Lymphoma and Myeloma, 9, S47-S48. https://doi.org/10.1016/s1557-9190(11)70531-5

@article{7ab38eda232849dcbd0ea0ce013c0ac2,

title = "A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients",

author = "H Lokhorst and P Wijermans and E Kneppers and G Huls and S Wittebol and P Sonneveld and E Vellenga and MJ Kersten and S Zweegman and M Schaafsma and RA Raymakers and C Eeltink",

year = "2012",

month = sep,

day = "27",

doi = "https://doi.org/10.1016/s1557-9190(11)70531-5",

language = "English",

volume = "9",

pages = "S47--S48",

journal = "Clinical Lymphoma and Myeloma",

issn = "1557-9190",

publisher = "Cancer Information Group, LP",

}

TY - JOUR

T1 - A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

AU - Lokhorst, H

AU - Wijermans, P

AU - Kneppers, E

AU - Huls, G

AU - Wittebol, S

AU - Sonneveld, P

AU - Vellenga, E

AU - Kersten, MJ

AU - Zweegman, S

AU - Schaafsma, M

AU - Raymakers, RA

AU - Eeltink, C

PY - 2012/9/27

Y1 - 2012/9/27

U2 - https://doi.org/10.1016/s1557-9190(11)70531-5

DO - https://doi.org/10.1016/s1557-9190(11)70531-5

M3 - Article

SN - 1557-9190

VL - 9

SP - S47-S48

JO - Clinical Lymphoma and Myeloma

JF - Clinical Lymphoma and Myeloma

ER -